Molecular Cancer Research · 2010 · 49 citations · 28 references
Life SciencesMolecular BiologyOncologyApoptosisDna RepairTranscriptional RegulationApoptosis In CancerApoptosis RegulationApoptosis ResistanceApoptotic SignalingChemotherapy ResistanceEpigenetic Regulation In CancerAntiapoptotic Protein RegulationAnticancer Drug ResistanceApoptotic Resistance MechanismsE2f Transcription ControlE2f Transcription Factor RegulationGlutathione BiosynthesisMolecular Drug ResistancePleiotropic Effects
Histone acetyltransferase (HAT) regulates transcription. We have previously shown that two HAT genes, Clock and Tip60, are overexpressed, and upregulate glutathione biosynthesis and the expression of DNA repair genes in cisplatin-resistant cells. To better understand the mechanism of HAT-related drug resistance, we investigated the role of another HAT gene, p300/CBP-associated factor (PCAF), and found that PCAF was also overexpressed in cisplatin-resistant cells and endowed an antiapoptotic phenotype through enhanced E2F1 expression. PCAF-overexpressing cells showed enhanced expression of E2F1 and conferred cell resistance to chemotherapeutic agents. Downregulation of PCAF decreased E2F1 expression and sensitized cells to chemotherapeutic agents. Moreover, knockdown of PCAF induced G(1) arrest and apoptosis. These results suggest that PCAF is one of pleiotropic factors for drug resistance and seems to be critical for cancer cell growth.
28
A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A
Xiang‐Jiao Yang, Vasily Ogryzko, Jun‐ichi Nishikawa et al. · Nature · 1996 · 1.5K citations
Glutathione-Associated Enzymes In Anticancer Drug Resistance
Kenneth D. Tew · Cancer Research · 2016 · 862 citations
Medicine, Biochemistry, Oncology +16
Role for the p53 homologue p73 in E2F-1-induced apoptosis
Meredith S. Irwin, María C. Marín, Andrew C. Phillips et al. · Nature · 2000 · 709 citations